Scientific rationale for the Finnish Allergy Programme 2008-2018: Emphasis on prevention and endorsing tolerance

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 5, 2009, Pages 678-701

  Von Hertzen, L C ^a   Savolainen, J ^b   Hannuksela, M ^c   Klaukka, T ^d   Lauerma, A ^e   Makela M J ^a   Pekkanen, J ^f   Pietinalho, A ^g   Vaarala, O ^f   Valovirta, E ^h   Vartiainen, E ^f   Haahtela, T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c Allergy and Asthma Federation in Finland   (Finland)

^d SOCIAL INSURANCE INSTITUTION   (Finland)

^e FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g Finnish Lung Health Association   (Finland)

^h Turku Allergy Center   (Finland)

Author keywords

Allergy; Asthma; Atopy; Avoidance; Finland; Programme; Tolerance

Indexed keywords

ALLERGEN; ANTIGEN; CYTOKINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN A ANTIBODY; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PLACEBO; PROBIOTIC AGENT; TOLL LIKE RECEPTOR; VENOM;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; CONTACT DERMATITIS; DENDRITIC CELL; DRUG MEGADOSE; FINLAND; FOLLOW UP; FOOD ALLERGY; GASTROINTESTINAL TRACT; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOTHERAPY; INTESTINE LYMPHATIC TISSUE; MICROORGANISM; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY SYSTEM; REVIEW; SAPROTROPH; SKIN FLORA; SKIN INFLAMMATION; UMBILICAL CORD BLOOD; URBANIZATION;

ALLERGENS; CLINICAL TRIALS AS TOPIC; CYTOKINES; FINLAND; GASTROINTESTINAL TRACT; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; IMMUNOTHERAPY; NATIONAL HEALTH PROGRAMS; PROBIOTICS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS;

EID: 63849157393     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02024.x     Document Type: Review

References (232)

1. Latvala J, Von Hertzen L, Lindholm H, Haahtela T. Trends in prevalence of asthma and allergy in Finnish young men: a nationwide study from 1966 to 2003. BMJ 2005 330 : 1186 1187.
2. Von Hertzen LC, Mäkelä MJ, Petäys T, Jousilahti P, Kosunen TU, Laatikainen T et al. Growing disparities in atopy between the Finns and the Russians - a comparison of two generations. J Allergy Clin Immunol 2006 117 : 151 157.
3. Allergiatoimikunnan Mietintö- Allergikommissionens Betänkande. Komiteamietintö-Kommittébetänkande. 1983 28. Helsinki : Ministry of Social Affairs and Health, 1983 (in Finnish and Swedish).
4. Allerginen kansa - Allergia kansanterveysongelmana. Konsensuskokous 11.11.1998, Hanasaari. Vammala : The Finnish Medical Association Duodecim and the Academy of Finland. 1998 (in Finnish).
5. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006 61 : 663 670.
6. Arion D (ed). Challenging dogmas in allergy. IAO-Workshop Berlin 2006. Brussels : The UCB Institute of Allergy, 2006.
7. Haahtela T, von Hertzen L, Mäkelä M, Hannuksela M, the Allergy Programme Working Group. Finnish Allergy Programme 2008-2018 - time to act and change the course. Allergy 2008 63 : 634 645.
8. Bousquet J, Khaltaev N (eds). Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Switzerland : WHO, 2007.
9. Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008 8 : 435 446.
10. Brandtzaeg P. Current understanding of gastrointestinal immunoregulation and its relation to food allergy. Ann NY Acad Sci 2002 964 : 13 45.
11. Böttcher MF, Häggström P, Björkstén B, Jenmalm MC. Total and allergen-specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age. Clin Exp Allergy 2002 32 : 1293 1298.
12. Westerberg LS, Klein C, Snapper SB. Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency - lessons learned from monogenic disorders in mice and man. Curr Opin Immunol 2008 20 : 646 654.
13. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994 91 : 6688 6692.
14. Burks AW, Laubach S, Jones SM. Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol 2008 121 : 1344 1350.
15. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995 376 : 177 180.
16. Meiler F, Zumkehr J, Klunker S, Rückert B, Akdis CA, Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008 205 : 2887 2898.
17. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003 33 : 1205 1214.
18. Francis JN, Till SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003 111 : 1255 1261.
19. Savolainen J, Laaksonen K, Rantio-Lehtimäki A, Terho EO. Increased expression of allergen induced in vitro IL-10 and IL-18 mRNA in PBMC of allergic rhinitis patients after specific immunotherapy. Clin Exp Allergy 2004 34 : 413 419.
20. Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001 357 : 752 756.
21. Savolainen J, Nieminen K, Laaksonen K, Laiho T, Jacobsen L, Lahesmaa R et al. Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy. Allergy 2007 62 : 949 953.
22. Holt PG, Thomas WR. Sensitization to airborne environmental allergens: unresolved issues. Nat Immunol 2005 6 : 957 960.
23. Secrist H, DeKruyff RH, Umetsu DT. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 1995 181 : 1081 1089.
24. Varney VA, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993 92 : 644 651.
25. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004 16 : 1643 1656.
26. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006 24 : 209 226.
27. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008 8 : 523 532.
28. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991 174 : 1209 1220.
29. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993 150 : 353 360.
30. Moore KM, De Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and interleukin-10 receptor. Annu Rev Immunol 2001 19 : 683 765.
31. Groux H, Bigler M, De Vries JE, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T-cells. J Exp Med 1996 184 : 19 29.
32. Pierkes M, Bellinghausen I, Hultsch T, Metz G, Knop J, Saloga J. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells. J Allergy Clin Immunol 1999 103 : 326 332.
33. Royer B, Varadaradjalou S, Saas P, Guillosson JJ, Kantelip JP, Arock M. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp Allergy 2001 31 : 694 704.
34. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998 16 : 137 161.
35. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994 265 : 1237 1240.
36. Weiner HL. Induction and mechanism of action of transforming growth factor-beta- secreting Th3 regulatory cells. Immunol Rev 2001 182 : 207 214.
37. Park SR, Seo GY, Choi AJ, Stavnezer J, Kim PH. Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching. Eur J Immunol 2005 35 : 946 956.
38. Cottrez F, Groux H. Regulation of TGF-beta response during T cell activation is modulated by IL-10. J Immunol 2001 167 : 773 778.
39. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007 450 : 566 569.
40. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001 194 : 629 644.
41. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cella and immune tolerance. Cell 2008 133 : 775 787.
42. Bacchetta R, Gambineri E, Roncarolo MG. Role of regulatory T cells and Foxp3 in human diseases. J Allergy Clin Immunol 2007 120 : 227 235.
43. Hawrylowicz CM, O'Carra AO. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005 5 : 271 283.
44. Taylor A, Vehagen J, Blaser K, Akdis M, Akdis CA. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology 2006 117 : 433 442.
45. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006 124 : 783 801.
46. Heine H, Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 2003 130 : 180 192.
47. Carneiro LA, Travassos LH, Girardin SE. Nod-like receptors in innate immunity and inflammatory diseases. Ann Med 2007 39 : 581 593.
48. Benko S, Philpott DJ, Girardin SE. The microbial and danger signals that activate Nod-like receptors. Cytokine 2008 43 : 368 373.
49. Le Bourhis L, Benko S, Girardin SE. Nod1 and Nod2 in innate immunity and human inflammatory disorders. Biochem Soc Transact 2007 35 : 1479 1484.
50. Lamkanfi M, Kanneganti TD, Franchi L, Nunez G. Caspase-1 inflammasomes in infection and inflammation. J Leukoc Biol 2007 82 : 220 225.
51. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microffora by Toll-like receptors is required for intestinal homeostasis. Cell 2004 118 : 229 241.
52. Hugot LP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al. Association NOD2 leucine-rich repeat variants with susceptibility to Cronhn's disease. Nature 2001 411 : 599 603.
53. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001 411 : 603 606.
54. McGovern DPB, Hysi P, Ahmad T, Van Heel DA, Moffatt MF, Carey A et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Gen 2005 14 : 1245 1250.
55. Weidunger S, Klopp N, Rummler L, Wagenpheil S, Novak N, Baurecht HJ et al. Association of NOD1 polymorphisms with atopic eczemaand related phenotypes. J Allergy Clin Immunol 2005 116 : 177 184.
56. Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, Braun-Fahrländer C et al. Association between exposure to farming, allergies and genetic variation in CARD4/NOD1. Allergy 2006 61 : 1117 1124.
57. Hysi P, Kabesch M, Moffatt MF, Schedel M, Carr D, Zhang Y et al. NOD1 variation, immunoglobulin E and asthma. Hum Molec Gen 2005 14 : 935 941.
58. Cottrez F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000 165 : 4848 4853.
59. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004 363 : 608 615.
60. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004 199 : 1567 1575.
61. Strobel S. Oral tolerance, systemic immunoregulation and autoimmunity. Ann NY Acad Sci 2002 958 : 47 58.
62. Smith M, Tourigny MR, Noakes P, Thornton CA, Tulic MK, Prescott SL. Children with egg allergy have evidence of reduced neonatal CD4(+)CD25(+) CD127(lo/-) regulatory T cell function. J Allergy Clin Immunol 2008 121 : 1460 1466.
63. Schaub B, Liu J, Höppler S, Haug S, Sattler C, Lluis A et al. Impairment of T-regulatory cells in cord blood of atopic mothers. J Allergy Clin Immunol 2008 121 : 1491 1499.
64. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005 307 : 1920 1925.
65. Strobel S, Mowat AM. Oral tolerance and allergic responses to food proteins. Curr Opin Allergy Clin Immunol 2006 6 : 207 213.
66. Lee J, Gonzales-Navajas JM, Raz E. The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin Immunopathol 2008 30 : 3 9.
67. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007 132 : 1359 1374.
68. Smith KM, Eaton AD, Finlayson LM, Garside P. Oral tolerance. Am J Respir Crit Care Med 2000 162 : S175 S178.
69. Savolainen J, Jacobsen L, Valovirta E. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 2006 61 : 1184 1190.
70. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007 120 : 707 713.
71. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, De Vries JE et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997 389 : 737 742.
72. Rescigno M, Lopatin U, Chieppa M. Interactions among dendritic cells, macrophages, and epithelial cells in the gut: implications for immune tolerance. Curr Opin Immunol 2008 20 : 669 675.
73. Tsuji NM, Mizumachi K, Kurisaki J. Antigen-specific, CD4+CD25+ regulatory T cell clones induced in Peyer's patches. Int Immunol 2003 15 : 525 534.
74. Frossard CP, Tropia L, Hauser C, Eigenmann PA. Lymphocytes in Peyer patches regulate clinical tolerance in a murine model of food allergy. J Allergy Clin Immunol 2004 113 : 958 964.
75. Beyer K, Castro R, Birnbaum A, Benkov K, Pittman N, Sampson HA. Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile. J Allergy Clin Immunol 2002 109 : 707 713.
76. Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004 199 : 1679 1688.
77. Shreffler WG, Wanich N, Moloney M, Nowak-Wegrzyn A, Sampson HA. Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol 2009 123 : 43 52.
78. Enrique E, Pineda F, Malek T, Bartra J, Basagaña M, Tella R et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005 116 : 1073 1079.
79. Lack G. Food allergy. N Engl J Med 2007 359 : 1252 1260.
80. Lack G. Epidemiologic risk factors for food allergy. J Allergy Clin Immunol 2008 121 : 1331 1336.
81. Poole JA, Barriga K, Donald YML, Michelle H, Eisenbarth GS, Rewers M, Norris JM. Timing of Initial Exposure to Cereal Grains and the Risk of Wheat Allergy. Pediatrics 2006 117 : 2175 2182.
82. Høst A, Halken S, Muraro A, Dreborg S, Niggemann B, Aalberse R et al. Dietary prevention of allergic diseases in infants and small children. Pediatr Allergy Immunol 2008 19 : 1 4.
83. Saarinen KM, Pelkonen AS, Mäkelä MJ, Savilahti E. Clinical course and prognosis of cow's milk allergy are dependent on milk-specific IgE status. J Allergy Clin Immunol 2005 116 : 869 875.
84. Boyano-Martínez T, García-Ara C, Díaz-Pena JM, Martín-Esteban M. Prediction of tolerance on the basis of quantification of egg white-specific IgE antibodies in children with egg allergy. J Allergy Clin Immunol 2002 110 : 304 309.
85. Saarinen KM, Juntunen-Backman K, Jarvenpaa AL, Klemetti P, Kuitunen P, Lope L et al. Breast-feeding and the development of cows' milk protein allergy. Adv Exp Med Biol 2000 478 : 121 130.
86. Hill DJ, Hosking CS, De Benedictis FM, Oranje AP, Diepgen TL, Bauchau V et al. Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clin Exp Allergy 2008 38 : 161 168.
87. Sly PD, Boner AL, Björksten B, Bush A, Custovic A, Eigenmann PA et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet 2008 372 : 1100 1106.
88. Zeiger RS. Food allergen avoidance in the prevention of food allergy in infants and children. Pediatrics 2003 111 : 1662 1671.
89. Greer FR, Sicherer SH, Burks AW, the Committee on Nutrition and Section on Allergy and Immunology. Effects of early nutritional interventions on the development of atopic disease in infants and children: The role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008 121 : 183 191.
90. Diez U, Borte M, Herbarth O, Wichmann HE, Heinrich J, Zutavern A et al. Timing of solid food introduction in relation to atopic dermatitis and atopic sensitization: results from a prospective birth cohort study. Pediatrics 2006 117 : 401 441.
91. Flinterman AE, Knulst AC, Meijer Y, Bruijnzeel-Koomen CA, Pasmans SG. Acute allergic reactions in children with AEDS after prolonged cow's milk elimination diets. Allergy 2006 61 : 370 374.
92. Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 2004 59 : 980 987.
93. Meglio P, Giampietro PG, Gianni S, Galli E. Oral desensitization in children with immunoglobulin E-mediated cow's milk allergy - follow-up at 4 yr and 8 months. Pediatr Allergy Immunol 2008 19 : 412 419.
94. Niggemann B, Staden U, Rolinck-Werninghaus C, Beyer K. Specific oral tolerance induction in food allergy. Allergy 2006 61 : 808 811.
95. Leung DY, Sampson HA, Burks AW Jr., Schneider LC, Wortel CH, Davis FM et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003 348 : 986 993.
96. Grewe M, Bruijnzeel-Koomen CA, Schöpf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998 19 : 359 361.
97. Grewe M, Czech W, Morita A, Werfel T, Klammer M, Kapp A et al. Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol 1998 161 : 415 420.
98. Akdis CA, Akdis M, Simon D, Dibbert B, Weber M, Gratzl S et al. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999 113 : 628 634.
99. Akdis CA, Blaser K, Akdis M. Apoptosis in tissue inflammation and allergic disease. Curr Opin Immunol 2004 16 : 717 723.
100. Verhagen J, Akdis M, Traidl-Hoffmann C, Schmid-Grendelmeier P, Hijnen D, Knol EF et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006 117 : 176 183.
101. Martin SF, Jakob T. From innate to adaptive immune responses in contact hypersensitivity. Curr Opin Allergy Clin Immunol 2008 8 : 289 293.
102. Cavani A, De Pità O, Girolomoni G. New aspects of the molecular basis of contact allergy. Curr Opin Allergy Clin Immunol 2007 7 : 404 408.
103. Schwarz A, Grabbe S, Riemann H, Aragane Y, Simon M, Manon S et al. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J Invest Dermatol 1994 103 : 211 216.
104. Ferguson TA, Dube P, Griffith TS. Regulation of contact hypersensitivity by interleukin 10. J Exp Med 1994 179 : 1597 1604.
105. Ghoreishi M, Dutz JP. Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J Immunol 2006 176 : 2635 2644.
106. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007 8 : 1095 1104.
107. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000 114 : 295 302.
108. Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pità O, Girolomoni G. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003 171 : 5760 5768.
109. Fierer N, Hamady M, Lauber CL, Knight R. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Nat Acad Sci 2008 105 : 17994 17999.
110. Miller LS, Modlin RL. Toll-like receptors in the skin. Semin Immunopathol 2007 29 : 15 26.
111. Bergmann R, Woodcock A. Whole population or high-risk group? Eur Respir J 1998 12 : 9S 12S.
112. Eder W, Klimecki W, Yu L, Von Mutius E, Riedler J, Braun-Fahrländer C et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004 113 : 482 488.
113. Haneda K, Sano K, Tamura G, Shirota H, Ohkawara Y, Sato T et al. Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the trachea. Am J Respir Cell Mol Biol 1999 21 : 268 274.
114. De Heer HJ, Hammad H, Soullié T, Hijdra D, Vos N, Willart MA et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004 200 : 89 98.
115. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, Rückert B et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004 114 : 1425 1433.
116. Tournoy KG, Van Hove C, Grooten J, Moerloose K, Brusselle GG, Joos GF. Animal models of allergen-induced tolerance in asthma: are regulatory-1 cells (Tr1) the solution for T-helper-2 cells)(Th2) in asthma? Clin Exp Allergy 2006 36 : 8 20.
117. Von Hertzen LC, Haahtela T. Disconnection of man and the soil - reason for the asthma and atopy epidemic? J Allergy Clin Immunol 2006 117 : 334 344.
118. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002 347 : 911 920.
119. Boasen J, Chrishol D, Lebet L, Akira S, Horner AA. House dust extract elicit Toll-like receptor-dependent dendritic cell responses. J Allergy Clin Immunol 2005 116 : 185 191.
120. Hessle C, Andersson B, Wold AE. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 2000 68 : 3581 3586.
121. Alenius H, Pakarinen J, Saris O, Andersson MA, Leino M, Sirola K et al. Contrasting immunological effects of two disparate dusts-preliminary observations. Int Arch Allergy Immunol 2008 149 : 81 90.
122. Roponen M, Hyvärinen A, Hirvonen MR, Keski-Nisula L, Pekkanen J. Change in IFNγ-producing capacity in early life and exposure to environmental microbes. J Allergy Clin Immunol 2005 116 : 1048 1052.
123. Ege MJ, Bieli C, Frei R, Van Strien RT, Riedler J, Ublagger E et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol 2006 117 : 817 823.
124. Eduard W, Douwes J, Omenaas E, Heederik D. Do farming exposures cause or prevent asthma? Results from a study of adult Norwegian farmers Thorax 2004 59 : 381 386.
125. Koskela HO, Happonen KK, Remes ST, Pekkanen J. Effect of farming environment on sensitisation to allergens continues after childhood. Occup Environ Med 2005 62 : 607 611.
126. Schaub B, Lauener R, Von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol 2006 117 : 969 977.
127. Von Mutius E. Influences in allergy: Epideniology and the environment. J Allergy Clin Immunol 2004 113 : 373 379.
128. Waser M, Michels KB, Bieli C, Flöistrup H, Pershagen G, Von Mutius E et al. Inverse association of farm milk consumption with asthma and allergy in rural and suburban populations across Europe. Clin Exp Allergy 2007 37 : 661 670.
129. Perkin MR, Strachan DP. Which aspects of the farming lifestyle explain the inverse association with childhood allergy? J Allergy Clin Immunol 2006 117 : 1374 1381.
130. Vartiainen E, Petäys T, Haahtela T, Jousilahti P, Pekkanen J. Allergic diseases, skin prick test responses, and IgE levels in North Karelia, Finland, and the Republic of Karelia, Russia. J Allergy Clin Immunol 2002 109 : 643 648.
131. Kondrashova A, Reunanen A, Romanov A, Karvonen A, Viskari H, Vesikari T et al. A sixfold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med 2005 37 : 67 72.
132. Rook GA, Adams V, Hunt J, Palmer R, Martinelle R, Brunet LR. Mycobacteria and other environmnetal organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immun 2004 25 : 237 255.
133. Von Hertzen L, Laatikainen T, Pitkänen T, Vlasoff T, Mäkelä MJ, Vartiainen E et al. Microbial content of drinking water in Finnish and Russian Karelia - implications for allergy prevalence. Allergy 2007 62 : 288 292.
134. Tannock GW. Normal microflora. An introduction to microbes inhabiting the human body. London : Chapman & Hall, 1995.
135. Gao Z, Tseng C, Pei Z, Blaser M. Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci 2007 104 : 2927 2932.
136. Zoetendal EG, Vaughan EE, De Vos WM. A microbial world within us. Molec Microbiol 2006 59 : 1639 1650.
137. van Strien R.T., Engel R., Holst O., Bufe A., Eder W., Waser M. et al. Microbial exposure of rural school children, as assessed by levels of N-acetyl-muramic acid in mattress dust, and ist association with respiratory health. J Allergy Clin Immunol 2004 113 : 860 867.
138. Douwes J, van Strien R, Doekes G, Smit J, Kerkhof M, Gerritsen J. Does early indoor microbial exposure reduce the risk of asthma? The prevention and incidence of asthma and mite allergy birth cohort study J Allergy Clin Immunol 2006 117 : 1067 1073.
139. Re F, Strominger JL. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 2004 173 : 7548 7555.
140. Sutmuller R, Den Brok M, Kramer M, Bennink E, Toonen L, Kullberg BJ et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006 116 : 485 494.
141. Taylor R, Richmond P, Upham JW. Toll-like receptor 2 ligands inhibit Th2 responses to mite allergen. J Allergy Clin Immunol 2006 117 : 1148 1154.
142. Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu YJ et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004 173 : 4433 4442.
143. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004 126 : 520 528.
144. Lauener RP, Birchier T, Adamski J, Braun-Fahrländer C, Bufe A, Herz U et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002 360 : 465.
145. Pakarinen J, Hyvärinen A, Salkinoja-Salonen M, Laitinen S, Nevalainen A, Mäkelä MJ, Haahtela T, von Hertzen L. Predominance of Gram-positive bacteria in house dust in the low-allergy risk Russian Karelia. Environ Microbiol 2008 10 : 3317 3325.
146. Alfven T, Braun-Fahrländer C, Brunekreef B, Von Mutius E, Riedler J, Scheynius A et al. Allergic diseases and atopic sensitisation in children related to farming and anthroposophic lifestyle - the PARSIFAL study. Allergy 2006 61 : 414 421.
147. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 1999 353 : 1485 1488.
148. Plengvidhya V, Breidt F, Lu Z, Fleming HP. DNA fingerprinting of lactic acid bacteria in sauerkraut fermentations. Appl Environ Microbiol 2007 73 : 7697 7702.
149. Lee MY, Ahn KS, Kwon OK, Kim MJ, Kim MK, Lee IY et al. Anti-inflammatory and anti-allergic effects of kefir in a mouse asthma model. Immunobiology 2007 212 : 647 654.
150. Liu JR, Wang SY, Chen MJ, Yueh PY, Lin CW. The anti-allergenic properties of milk kefir and soymilk kefir and their beneficial effects on the intestinal microflora. J Sci Food Agric 2006 86 : 2527 2533.
151. Voorhorst R, Spieksma-Boezeman ML, Spieksma FT. Is a mite (Dermatophagoides sp.) the producer of the house dust allergen? Allergie Asthma 1964 10 : 329 334.
152. Platts-Mills TAE, Woodfolk JA, Erwin EA, Aalberse R. Mechanisms of tolerance to inhalant allergens: the relevance of a modified Th2 response to allergens from domestic animals. Springer Semin Immun 2004 25 : 271 279.
153. Cullinan P, MacNeill SJ, Harris JM, Moffat S, White C, Mills P et al. Early allergen exposure, skin prick responses, and atopic wheeze at age 5 in English children: a cohort study. Thorax 2004 59 : 855 861.
154. Johnson CC, Ownby D, Havstad S, Peterson EL. Family history, dust mite exposure in early childhood and risk for pediatric atopy and asthma. J Allergy Clin Immunol 2004 114 : 105 110.
155. Polk S, Sunyer J, Munoz.Ortiz L, Barnes M, Torrent M, Figueroa C et al. A prospective study of Feld 1 and Der p1 exposure in infancy and childhood wheezing. Am J Respir Crit Care Med 2004 170 : 273 278.
156. Torrent M, Sunyer J, Garcia R, Harris J, Iturriaga MV, Puig C et al. Early-life allergen exposure and atopy, asthma and wheeze up to 6 years of age. Am J Respir Crit Care Med 2007 176 : 446 453.
157. Lau S, Illi S, Sommerfeld C, Niggemann B, Bergmann R, Von Mutius E et al. Early exposure to house dust mite and cat allergens and development of childhood asthma: a cohort study. Lancet 2000 356 : 1392 1397.
158. Carter PM, Peterson EL, Ownby DR, Zoratti EM, Johnson CC. Relationship of house-dust mite allergen exposure in children's bedrooms in infancy to bronchial hyperresponsiveness and asthma diagnosis by age 6 to 7. Ann Allergy Asthma Immunol 2003 90 : 41 44.
159. Von Mutius E. Paediatric origin of adult lung disease. Thorax 2001 56 : 153 157.
160. Gotzsche PC, Johansen HK. House dust mite control measures for asthma. Cochrane Database Syst Rev 2008 1 : CD001187.
161. Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2007 1 : CD001563.
162. Remes ST, Koskela HO, Iivanainen K, Pekkanen J. Allergen-specific sensitisation in asthma and allergic diseases in children: the study on farmers' and non-farmers' children. Clin Exp Allergy 2005 35 : 160 166.
163. Braun-Farhländer C, Riedler J, Herz U, Eder W, Waser M, Grize L et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002 347 : 869 877.
164. Kilpeläinen M, Terho EO, Helenius H, Koskenvuo M. Childhood farm environment and asthma and sensitisation in young adulthood. Allergy 2002 57 : 1130 1135.
165. Von Hertzen LC, Laatikainen T, Pennanen S, Mäkelä MJ, Haahtela T, the Karelian Allergy Study Group. Is house dust mite monosensitization associated with clinical disease? Allergy 2008 63 : 379 381.
166. Schram-Bijkerk D, Doekes G, Boeve M, Douwes J, Riedler J, Üblagger E et al. Nonlinear relations between house dust mite allergen levels and mite sensitisation in farm and nonfarm children. Allergy 2006 61 : 640 647.
167. Müller UR. Bee venom allergy in bee keepers and their family members. Curr Opin Allergy Immunol 2005 5 : 343 347.
168. Custovic A, Hallam CL, Simpson BM, Craven M, Simpson A, Woodcock A. Decreased prevalence of sensitization to cats with high exposure to cat allergen. J Allergy Clin Immunol 2001 108 : 537 539.
169. Ownby DR, Johnson CC, Peterson EL. Exposure to dogs and cats in the first year of life and risk of allergic sensitisation at 6 to 7 years. JAMA 2002 288 : 963 972.
170. Jeal H, Draper A, Harris J, Taylor AN, Cullinan P, Jones M. Modified Th2 responses at high-dose exposures to allergen - using an occupational model. Am J Respir Crit Care Med 2006 174 : 21 25.
171. Matsui EC, Eggleston PA, Breysse PN, Rand CS, Diette GB. Mouse allergen-specific antibody responses in inner-city children with asthma. J Allergy Clin Immunol 2007 119 : 910 915.
172. Gotzsche PC, Johansen HK, Schmidt LM, Burr ML. House dust mite control measures for asthma. Cochrane Database Syst Rev 2008 16 : CD001187.
173. Van Schayck OCP, Maas T, Kaper J, Knottnerus AJ, Sheikh A. Is there any role for allergen avoidance in the primary prevention of childhood asthma? J Allergy Clin Immunol 2007 119 : 1323 1328.
174. O'Connor GT. Allergen avoidance in asthma: What do we do now? J Allergy Clin Immunol 2005 116 : 26 30.
175. Savilahti E, Kuitunen M, Vaarala O. Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol 2008 8 : 243 248.
176. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008 121 : 116 121.
177. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003 361 : 1869 1871.
178. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2008 119 : 192 198.
179. Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Haahtela T, Savilahti E. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009 123 : 335 341.
180. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997 159 : 1739 1745.
181. Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol 2005 16 : 433 438.
182. Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002 57 : 243 246.
183. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004 145 : 612 616.
184. Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 2005 16 : 65 71.
185. Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008 38 : 611 618.
186. Viljanen M, Pohjavuori E, Haahtela T, Korpela R, Kuitunen M, Sarnesto A et al. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol 2005 115 : 1254 1259.
187. Mueller HL, Lanz M. Hyposensitization with bacterial vaccine in infectious asthma. A double-blind study and a longitudinal study. JAMA 1969 208 : 1379 1383.
188. Malling HJ. Bacterial vaccines: anything but placebo. Allergy 2000 55 : 214 218.
189. Kim HG, Kim NR, Gim MG, Lee JM, Lee SY, Ko MY et al. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-alpha production in THP-1 cells and endotoxin shock in mice. J Immunol 2008 180 : 2553 2561.
190. Wang Q, McLoughlin RM, Cobb BA, Charrel-Dennis M, Zaleski KJ, Golenbock D et al. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med 2006 203 : 2853 2863.
191. Zuany-Amorin C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemery DM et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T cells. Nat Med 2002 8 : 625 629.
192. Adams VC, Hunt JR, Martinelli R, Palmer R, Rook GA, Brunet LR. Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potentila in allergic mice. Eur J Immunol 2004 34 : 631 638.
193. Shirtcliffe PM, Easthope SE, Cheng S, Weatherall M, Tan PL, Le Gros G et al. The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobactrium vaccae in asthma. Am J Respir Crit Care Med 2001 163 : 1410 1414.
194. Camporata L, Corkhill A, Long H, Lordan J, Stanciu L, Tuckwell N et al. The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur Respir J 2003 21 : 287 293.
195. Berth-Jones J, Arkwright PD, Marasovic D, Savani N, Alridge CR, Leech SN et al. Killed Mycobacterium vaccae suspension in children with moderate-to severe atopic dermatitis; a randomised, double-bblind, placebo-controlled trial. Clin Exp Allergy 2006 36 : 1115 1121.
196. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001 107 : 531 534.
197. Kitagaki K, Jain VV, Businga TR, Hussain I, Kline JN. Immunomodulatory effects of CpG oligonucleotides on established Th2 responses. Clin Diagn Lab Immunol 2002 9 : 1260 1269.
198. Kline JN. Eat dirt: CpG DNA and immunomodulation of asthma. Proc Am Thorac Soc 2007 4 : 283 288.
199. Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006 355 : 1445 1455.
200. Yazdanbakhsh M, Kremsner PG, Van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002 296 : 490 494.
201. Yazdanbakhsh M, Wahyuni S. The role of helminth infections in protection from atopic disorders. Curr Opin Allergy Clin Immunol 2006 5 : 366 391.
202. Summers RW, Elliott DE, Urban JF Jr., Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005 128 : 825 832.
203. Falcone FH, Pritchard DI. Parasite role and reversal: worms on trial. Trends in Parasitol 2005 21 : 157 160.
204. Smits HH, Yazdanbakhsh M. Chronic helminth infections modulate allergen-specific immune responses: Protection against development of allergic disorders? Ann Med 2007 39 : 428 439.
205. Matricardi PM, Bonini S. Mimicking microbial 'education' of the immune system:a strategy to revert the epidemic trend of atopy and allergic asthma? Respir Res 2000 1 : 129 132.
206. Matricardi PM, Björksten B, Bonini S, Bousquet J, Djukanoic R, Dreborg S et al. Microbial products in allergy prevention and therapy. Allergy 2003 58 : 461 471.
207. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007 1 : CD001936.
208. Pajno G. Sublingual immunotherapy: The optimism and the issues. J Allergy Clin Immunol 2007 119 : 796 801.
209. Passalacqua G, Durham SR, the Global Allergy an Asthma European Network. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 2007 119 : 881 891.
210. Halken S, Lau S, Valoavirta E. New visions in specific immunotherapy in children: an iPAC summary and future trends. Pediatr Allergy Immunol 2008 19 (suppl 19 60 70.
211. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998 102 : 558 562.
212. Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E. EAACI standards for allergen specific immunotherapy. Allergy 2006 61 (Suppl 82 1 20.
213. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Höst A et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007 62 : 943 948.
214. Poulsen PB, Pedersen KM, Christensen J, Vestenbaek U. Economic evaluation of a tablet-based vaccination against hay fever in Denmark. Ugeskr Laeger 2008 170 : 138 142. (in Danish, summary in English).
215. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-toTh1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997 27 : 1131 1139.
216. Akdis CA, Blesken T, Akdis M, Wütrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998 102 : 98 106.
217. Radulovic S, Jacobson MR, Durham SR, Nouri-Aria KT. Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol 2008 121 : 1467 1472.
218. Valovirta E, Jacobsen L, Liorring C, Koivikko A, Savolainen J. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006 61 : 1177 1183.
219. Johansson SO, Haahtela T. World Allergy Organization guidelines for prevention of allergy and allergic asthma. Int Arch Allergy Immnol 2004 135 : 83 92.
220. Karjalainen J, Virta M, Pessi T, Hulkkonen J, Nieminen MM, Hurme M. Childhood cat exposure-related tolerance is associated with IL1A and IL10 polymorphisms. J Allergy Clin Immunol 2005 116 : 223 225.
221. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008 372 : 1049 1057.
222. Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002 109 : 251 256.
223. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma, ARIA. J Allergy Clin Immunol 2001 108 : S147 S336.
224. Valovirta E, Myrseth SE, Palkonen S. The voice of the patients: allergic rhinitis is not a trivial disease. Curr Opin Allery Clin Immunol 2008 8 : 1 9.
225. Rogers EM. Communication campaigns to change health-related lifestyles. Hygie 1992 11 (Suppl 2 29 35.
226. Puska P, Pietinen P, Uusitalo U. Influencing public nutrition for non-communicable disease prevention: from community intervention to national programme - experiences from Finland. Public Health Nutr 2002 5 : 245 251.
227. Beasley R, Keil U, Von Mutius E, Pearce N, ISAAC Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema: ISAAC. Lancet 1998 351 : 1225 1232.
228. European Community Respiratory Health Survey (ECRHS). Variations in the prevalence of respiratory symptoms, self reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996 9 : 687 695.
229. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phase One and Three repeat multicountry cross-sectional surveys. Lancet 2006 368 : 733 743.
230. Social Insurance Institute Publications 1996. A population survey in primary health care. Helsinki : Social Insurance Institute, 1996 (English summary).
231. Custovic A, Simpson A, Pahdi H, Green RM, Chapman MD, Woodcock A. Distribution, aerodynamic characteristics, and removal of the major cat allergen Fel d 1 in British homes. Thorax 1998 53 : 33 38.
232. Gore RB, Curbishley L, Truman N, Hadley E, Woodcock A, Langley SJ et al. Intranasal air sampling in homes: Relationships among reservoir allergen concentrations and asthma severity. J Allergy Clin Immunol 2006 117 : 649 655.